Roundhill GLP-1 & Weight Loss ETF (NQ: OZEM )

26.67 -0.25 (-0.93%)

Official Closing Price Updated: 4:15 PM EDT, Jul 30, 2024 Add to My Watchlist

Price and Volume

Volume	57,230
Open	27.13
Bid (Size)	26.00 (3)
Ask (Size)	27.81 (4)
Prev. Close	26.92
Today's Range	26.38 - 27.19
52wk Range	24.51 - 28.66
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'

July 18, 2024

Eli Lilly and Novo Nordisk face selloff as new weight-loss drugs threaten dominance. Shares of both companies drop significantly, highlighting need for diversification in this industry.

Via Benzinga

ETFs Bet High On Weight Loss Drugs, But Industry Observers Question Long-Term Potential

June 07, 2024

New ETFs focusing on weight-loss drugs have launched. However, industry observers caution about their long-term prospects and the concentrated risks associated with these investments.

Via Benzinga

Performance

YTD	+5.12%	+5.12%
1 Month	-1.62%	-1.62%
3 Month	+5.12%	+5.12%
6 Month	+5.12%	+5.12%
1 Year	+5.12%	+5.12%

More News

New Weight Loss ETF Is Essentially A Play On Eli Lilly, Novo Nordisk

May 30, 2024

Via Benzinga

Tesla (TSLA) Stock Drops as Glass Lewis Urges Against Elon Musk’s Pay Package

May 28, 2024

Via InvestorPlace

Campbell Soup Layoffs 2024: What to Know About New Campbell Job Cuts

May 28, 2024

Via InvestorPlace

OZEM ETF: 7 Things to Know About the New Roundhill GLP-1 & Weight Loss ETF

May 28, 2024

Via InvestorPlace

South Park Took On Crypto, AI Previously: Animated Comedy Targets Weight-Loss Drug Ozempic Next

May 23, 2024

Via Benzinga

EXCLUSIVE: Roundhill Investments Launches Weight Loss ETF For Exposure To Blockbuster Drugs Like Ozempic

May 21, 2024

Via Benzinga

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.